|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 532.9 USD | +0.13% |
|
+5.12% | +13.01% |
| Apr. 23 | TD Cowen Adjusts Elevance Health's Price Target to $624 From $555 | MT |
| Apr. 19 | UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating | MT |
Elevance Health Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 156,595 million compared to USD 138,639 million a year ago. Net income was USD 6,025 million compared to USD 6,104 million a year ago.
Diluted earnings per share from continuing operations was USD 24.81 compared to USD 24.73 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.01% | 124B | |
| +17.77% | 100B | |
| +2.18% | 40.43B | |
| -28.36% | 39.21B | |
| +0.53% | 21.2B | |
| -12.86% | 3.18B | |
| -39.84% | 947M | |
| -33.84% | 308M |
ELEVANCE HEALTH, INC. 
